Journal of Immunology Research (Jan 2017)

Beneficial Effects of Prebiotic Saccharomyces cerevisiae Mannan on Allergic Asthma Mouse Models

  • D. Betty Lew,
  • Christie F. Michael,
  • Tracie Overbeck,
  • W. Scout Robinson,
  • Erin L. Rohman,
  • Jeffrey M. Lehman,
  • Jennifer K. Patel,
  • Brandi Eiseman,
  • Kim S. LeMessurier,
  • Amali E. Samarasinghe,
  • M. Waleed Gaber

DOI
https://doi.org/10.1155/2017/3432701
Journal volume & issue
Vol. 2017

Abstract

Read online

One of the unmet needs for asthma management is a new therapeutic agent with both anti-inflammatory and anti-smooth muscle (ASM) remodeling effects. The mannose receptor (MR) family plays an important role in allergen uptake and processing of major allergens Der p 1 and Fel d 1. We have previously reported that ASM cells express a mannose receptor (ASM-MR) and that mannan derived from Saccharomyces cerevisiae (SC-MN) inhibits mannosyl-rich lysosomal hydrolase-induced bovine ASM cell proliferation. Using a humanized transgenic mouse strain (huASM-MRC2) expressing the human MRC2 receptor in a SM tissue-specific manner, we have demonstrated that ASM hyperplasia/hypertrophy can occur as early as 15 days after allergen challenge in this mouse model and this phenomenon is preventable with SC-MN treatment. This proof-of-concept study would facilitate future development of a potential asthma therapeutic agent with dual function of anti-inflammatory and anti-smooth muscle remodeling effects.